Improving the Gastrointestinal Tolerability of Fumaric Acid Esters: Early Findings on Gastrointestinal Events with Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis from the Phase 3, Open-Label EVOLVE-MS-1 Study
Material type:
TextSubject(s): Online resources:
| Item type | Current library | Call number | URL | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
eBooks
|
Link to resource | Available |
eBooks
There are no comments on this title.